Vaccines will be offered free of charge to those aged eighteen and over, Prime Minister Narendra Modi has announced. The Prime Minister announced the free vaccines policy during an address to the nation yesterday, in which he stated “the Government of India itself will buy 75 percent of the total vaccine production from vaccine manufacturers …
Free vaccines from the Centre; A federalised policy a welcome shift Read More »
The COVAX facility designed to ensure equitable access to COVID-19 vaccines received a boost earlier this week to the tune of US$2.4 billion, following a summit where countries and private donors made the mammoth commitment. Nonetheless, the facility still reels from India’s step back understandable though it may be. COVAX is jointly led by the …
COVAX gets boon from multi-billion dollar commitment – but India’s absence leaves a hole Read More »
Trials of Covaxin, India’s indigenously-manufactured COVID-19 vaccine candidate, are set to begin among young people to test its immunogenicity, reactogenicity, and safety. Trials among those aged between twelve and eighteen years are set to commence across five institutes throughout India. The institutes in question are the All India Institute of Medical Sciences (AIIMS) in Bihar …
Patent waivers for COVID-19 vaccines have been offered up as a suggestion as a means to address the global crisis. While in theory this would allow a shift in production from high-income nations to developing countries, achieving this requires overcoming a significant hurdle – a lack of production capacity. Recently, World Health Organization (WHO) Director-General …
Patent waivers unlikely to resolve COVID-19 vaccine crisis Read More »
Every Indian aged 45 and above will be eligible to receive a COVID-19 vaccine as of April 1st, the Government has said. Government minister Prakash Javadekar briefed reporters on the development following a meeting of the Union Cabinet chaired by Prime Minister Narendra Modi. Javadekar urged vaccine uptake, stating “I urge all above the age …
COVID-19 vaccines for all above 45 from April 1st, Govt. says Read More »
Both the Indian government and the World Health Organization (WHO) have addressed recent concerns surrounding the Oxford University/AstraZeneca COVID-19 vaccine and blood clots. Recent days saw multiple nations in Europe suspend use of the vaccine in their inoculation programmes as a precautionary measure. France, Germany, Italy, and Spain are among the countries to have taken …
AstraZeneca vaccine blood clots concerns addressed by Indian Government and WHO Read More »
Subrahmanyam Jaishankar, the Union Minister of External Affairs, has touted India’s role as ‘pharmacy of the world’. Jaishankar highlighted the country’s role in exporting vital medicines and equipment, amidst the country’s growing role as an exporter of vaccines against COVID-19. “India could meet the spiking requirements of hydroxychloroquine, paracetamol and other relevant drugs across the …
Pharmacy of the world: Jaishankar touts India’s role in global medical supply Read More »
The global vaccination campaign against COVID-19 is scaling up. However, the vaccine drive continues to miss out many countries. Since the vaccine drive commenced in December, more than 345 million vaccine doses have been administered. India began its own vaccine drive in January and, as of Sunday, has administered 29.74 million doses. 24.31 million people …
Global vaccine drive scaling up, but inequities remain Read More »
Covaxin, India’s homegrown COVID-19 vaccine candidate, has shown promising results in interim phase-III trials. The vaccine, manufactured by Hyderabad, Telangana-headquartered firm Bharat Biotech, demonstrated an almost 81 percent interim clinical efficacy according to the company following the release of results from the interim phase-III trials on Wednesday. “Covaxin demonstrates high clinical efficacy trend against COVID-19 …
Today marks the culmination of the fourth International HPV Awareness Campaign, coinciding with International HPV Awareness Day. Raising awareness of HPV [the human papillomavirus] is essential in the fight against cancer – most prominently cervical cancer. As the World Health Organization (WHO) explains, “there are more than 100 types of HPV, of which at least …
HPV awareness the need of the hour to fight cervical cancer Read More »
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
